Advanced Chemical Industries (ACI) PLC has announced the launch of a new subsidiary named ACI Biosciences Limited, with an authorized capital of BDT 1 billion. ACI will hold 90% of the shares, pending regulatory approval. Despite recent financial losses, including a loss of BDT 9.11 per share in the first three quarters of 2024-25, the company continues to invest in growth. ACI’s latest credit rating remains strong, reflecting confidence in its long-term stability.